11 4 Suppl : S5—11 | "Microbial complement inhibitors as vaccines" |
---|---|
"Development of a DIVA Differentiating Infected from Vaccinated Animals strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza" | "Evaluating the impact of human papillomavirus vaccines" |
"The role of intellectual property in the global challenge for immunization".
Olesen OF, Lonnroth A, Mulligan B 2009 | Kaashoek MJ, Moerman A, Madic J, Rijsewijk FAM, Quak J, Gielkens ALJ, Van Oirschot JT 1994 |
---|---|
Public Health Agency of Canada | South African Institute for Medical Research |
Patel, JR; Heldens, JG March 2009 | "Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay" |
---|---|
"Adverse events following immunization: perception and evidence" | Plasmids: Current Research and Future Trends |
"Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs".
8